LATEST ARTICLES

Arbitrary Age Limits Prevent Access to Clinical Trials for Adolescents and Young Adults

Arbitrary age limits in pediatric trials hinders appropriate access to clinical trials for young adults with specific pediatric cancer types. As a result, young cancer patients are often stuck in...

Breast Cancer Drugs for Women are Effective and Well-tolerated in Men

Breast cancer generally occurs in women, but men can get the disease too. According to the largest real-life study yet to investigate treatment and outcomes in men with breast cancer...

Study Shows Multi-strain Probiotic Reduces Chemotherapy-induced Diarrhea

Results from a phase II/III study conducted in India* shows that a high concentration of multi-strain probiotic helps to reduce mild to moderate episodes of chemotherapy-induced diarrhea (CID) in...

Positive Phase I Clinical Data Presented for Cantargia’s Nidanilimab

Results from the CANFOUR clinical trial presented in a poster presentation during the annual meeting of the European Society for medical Oncology (ESMO 2018), held October 19 - 24, 2018...

Oncologists need More Education about the Use of Biosimilars

Biological medicines, generally referred to as 'biologics' are responsible for some of the most promising innovations in the treatment of cancer, including immunotherapy, targeted drugs and vaccines. However, these...

Atezolizumab + Nab-paclitaxel Improves Outcomes as Initial Treatment of PD-L1-Positive mTNBC

Data presented at the European Society for Medical Oncology (ESMO) 2018 Congress, held October 19 - 23, 2018 in Munich, Germany and simultaneously published in the New England Journal...